APIs for research and impurities
Subcategories of "APIs for research and impurities"
- Aminoacids and derivatives(12,331 products)
- Anthraquinones and derivatives(404 products)
- Benzimidazole and Imidazole Derivatives(10,435 products)
- Benzodiazepine Derivatives(333 products)
- Carbohydrates and glycoconjugates(5,047 products)
- Esters and Derivatives(42,250 products)
- Fatty Acids and Lypidic Derivatives(32,401 products)
- Flavonoids and Polyphenols(17,080 products)
- Free Radicals and Oxidant/Reducing Agents(212 products)
- Ketones and derivatives(2,400 products)
- Natural and semi-synthetic antibiotics(6,371 products)
- Nitriles and Cyano Derivatives(3,068 products)
- Nitrosamines and Derivatives(55 products)
- Nucleosides and Nucleotides(3,470 products)
- Organic Phosphates and Phosphonates(1,199 products)
- Organic Sulphonates and Sulphates(10,430 products)
- Organometallics(4,421 products)
- Others(6,295 products)
- Peptides and Proteins(3,143 products)
- Polymers and Derivatives(100 products)
- Purines and Pyrimidine Derivatives(8,934 products)
- Quinazoline and Quinoline Derivatives(65,934 products)
- Quinones and Derivatives(24,356 products)
- Salts and Derivatives of Active Pharmaceutical Ingredients (API)(80,667 products)
- Steroids and Derivatives(4,946 products)
- Sulfonamides and Derivatives(2,587 products)
- Terpenoids and Derivatives(3,843 products)
- Thiazolidinediones and Thiopyrans(2,753 products)
- β-Adrenergic Compounds(230 products)
Found 58049 products of "APIs for research and impurities"
Fluphenazine decanoate EP impurity F
CAS:Controlled ProductFluphenazine decanoate EP impurity F is an analytical impurity of fluphenazine decanoate. This compound is a natural metabolite of the drug product, which is used to treat schizophrenia and other psychotic disorders. The synthesis of this compound is accomplished by custom synthesis or by synthesis from other synthetic compounds. Fluphenazine decanoate EP impurity F can be identified through HPLC analysis, as well as through its specific retention time on a chromatogram. Fluphenazine decanoate EP impurity F has been shown to have pharmacopoeia purity levels and is suitable for use as a reference standard in pharmacopoeial assays.Formula:C33H46F3N3O2SPurity:Min. 95%Molecular weight:605.8 g/mol5-Chloro-2-(4-chlorophenoxy)phenol 1-acetate
CAS:Please enquire for more information about 5-Chloro-2-(4-chlorophenoxy)phenol 1-acetate including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C14H10Cl2O3Purity:Min. 95%Molecular weight:297.1 g/molBenidipine 5-(1-benzylpiperidin-3-yl)
CAS:Benidipine 5-(1-benzylpiperidin-3-yl) is a potent calcium channel blocker that is used to treat hypertension. It contains mannitol and acts as a kinase inhibitor, which has been shown to have anticancer properties. Benidipine inhibits the growth of cancer cells by inducing apoptosis and suppressing protein synthesis. This drug has been studied extensively in Chinese medicinal research for its tumor-inhibiting effects, and it has demonstrated promising results in human urine samples. Benidipine is an analog of other medicinal inhibitors and has shown efficacy against various types of cancer cells.Formula:C28H31N3O6Purity:Min. 95%Molecular weight:505.6 g/molPDdEC-NB
CAS:Please enquire for more information about PDdEC-NB including the price, delivery time and more detailed product information at the technical inquiry form on this page
Formula:C16H16N2O5S2Purity:Min. 95%Molecular weight:380.4 g/molMetformin EP Impurity B Dinitrate
CAS:Metformin EP Impurity B Dinitrate is a metabolite of metformin. Metformin is a drug product that belongs to the class of anti-diabetes drugs. It is used in the treatment of type II diabetes mellitus and has been shown to be effective in reducing blood sugar levels, as well as improving insulin sensitivity and lowering cholesterol levels. Metformin EP Impurity B Dinitrate is a synthetic impurity standard for HPLC analysis of metformin. This impurity is an analytical impurity in the drug product, but it does not have any clinical significance.Formula:C4H8N8·2HNO3Purity:Min. 95%Molecular weight:294.19 g/mol3-[2-[(5-Ethyl-2-pyridinyl)ethoxy]phenyl] Pioglitazone Impurity
CAS:3-[2-[(5-Ethyl-2-pyridinyl)ethoxy]phenyl] Pioglitazone Impurity is a drug product that is used for analytical purposes and as a research and development standard. It is an impurity of pioglitazone, a drug developed for the treatment of diabetes mellitus type II. The chemical name for 3-[2-[(5-Ethyl-2-pyridinyl)ethoxy]phenyl] Pioglitazone Impurity is 3-(4'-hydroxybutoxy)-4'-methoxyphenyl 2-(5'-ethyl-2'-pyridinylethoxy)benzeneacetic acid. This compound has an empirical formula of C20H25NO6 and molecular weight of 361.39 g/mol. The CAS number is 952187-99-4.Formula:C34H35N3O4SPurity:Min. 95%Molecular weight:581.73 g/molN-(2-((2-(4-(2-(2-Hydroxyethoxy)ethyl)piperazine-1-carbonyl)phenyl)thio)phenyl)acetamide
CAS:N-(2-((2-(4-(2-(2-Hydroxyethoxy)ethyl)piperazine-1-carbonyl)phenyl)thio)phenyl)acetamide is a synthetic drug that has been developed for the treatment of various diseases. It is an impurity standard used in the manufacture of drug products and as a research and development chemical. Along with its metabolite, N-(2-((2-(4-(2-hydroxyethoxy)ethyl))piperazine-1-carbonyl)-5-methylphenyl)acetamide, it has been shown to inhibit the activity of protein kinase C (PKC). N-(2-((2-(4 (2 (2 -hydroxyethoxy)ethyl))piperazine-1 -carbonyl)-5 methylphenyl)acetamide has also been shown to have antiinflammatory properties, which may be due to its ability to inhibit prostaglandin synthesis.Formula:C23H29N3O4SPurity:Min. 95%Molecular weight:443.60 g/mol3’-Destrifluoromethyl 2’-trifluoromethyl cinacalcet
CAS:3' - Destrifluoromethyl 2' - trifluoromethyl cinacalcet is a metabolite of cinacalcet, which is a drug used for the treatment of secondary hyperparathyroidism. It is an impurity in the drug product and can be identified by HPLC.Formula:C22H22F3NPurity:Min. 95%Molecular weight:357.41 g/mol3alpha-Hydroxy pravastatin sodium salt
CAS:3alpha-Hydroxy pravastatin sodium salt is a white to off-white crystalline powder. It is used as an analytical standard for 3alpha-hydroxypravastatin and its metabolites. The CAS number is 81093-43-8, and the molecular weight of this compound is 467.6 g/mol. This product can be custom synthesized to meet your needs.Formula:C23H35NaO7Purity:Min. 95%Color and Shape:Off-White PowderMolecular weight:446.51 g/mol7-Hydroxydibenz[b,f][1,4]oxazepin-11(10H)-one
CAS:Please enquire for more information about 7-Hydroxydibenz[b,f][1,4]oxazepin-11(10H)-one including the price, delivery time and more detailed product information at the technical inquiry form on this page
Formula:C13H9NO3Purity:Min. 95%Molecular weight:227.21 g/molEtifoxine-d3
CAS:Controlled ProductPlease enquire for more information about Etifoxine-d3 including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C17H17ClN2OPurity:Min. 95%Molecular weight:303.8 g/molBendamustine deschloro dimer impurity
CAS:Bendamustine deschloro dimer impurity is a Chinese medicinal compound that acts as an inhibitor of kinases, which are enzymes that play a crucial role in the regulation of cell growth and division. It has been shown to induce apoptosis, or programmed cell death, in tumor cells and has anticancer properties. Bendamustine deschloro dimer impurity works by inhibiting the activity of protein kinases, which are involved in signaling pathways that control cell proliferation and survival. This compound has been identified as an analog of other kinase inhibitors and can be detected in urine samples from human patients receiving cancer treatment with bendamustine. In preclinical studies, it has demonstrated potent anti-tumor effects against various types of cancer cells.Formula:C32H44N6O7Purity:Min. 95%Molecular weight:624.7 g/molEthyl 3,6-dioxocyclohexa-1,4-diene-1-sulfonate
CAS:Ethyl 3,6-dioxocyclohexa-1,4-diene-1-sulfonate is an analog that has shown potential as an anticancer agent. It works by inhibiting kinases that are involved in cancer cell growth and proliferation. Studies have shown that this compound induces apoptosis in human tumor cells, making it a promising candidate for cancer treatment. Ethyl 3,6-dioxocyclohexa-1,4-diene-1-sulfonate has also been found to be a potent inhibitor of protein kinase D (PKD), which plays a key role in cancer cell survival and proliferation. This compound has been compared to the well-known kinase inhibitor saxagliptin and found to be more effective at inhibiting PKD activity. Additionally, Chinese hamster ovary cells treated with Ethyl 3,6-dioxocyclohexa-1,4-diene-1-sulfonate showed reduced levels of urinary exFormula:C12H12CaO11S2Purity:Min. 95%Molecular weight:436.4 g/mol[6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-7-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone
CAS:6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-7-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone is a synthetic impurity standard that is used as a reference material in the analytical, natural and drug development, and metabolite studies. 6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-7-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone has a molecular weight of 390.27 and chemical formula C26H28N2O3S. It is also referred to by its CAS number 1391054-73-1.6Formula:C28H27NO4SPurity:Min. 95%Molecular weight:473.58 g/molDtpa-bma
CAS:Dtpa-bma is an anticancer agent that acts as a kinase inhibitor. It has been shown to induce apoptosis in cancer cells by inhibiting the activity of kinases, which are enzymes that play a key role in cell signaling pathways. Dtpa-bma is an analog of Chinese hamster ovary (CHO) cell-derived ghrelin and is excreted in urine. This drug is effective against various types of cancer, including human tumors, and has been shown to inhibit tumor growth in vivo. Dtpa-bma is formulated as a cellulose-based resin for use in chromatography purification processes.Formula:C16H29N5O8Purity:Min. 95%Molecular weight:419.43 g/molLevothyroxine EP impurity B
CAS:Please enquire for more information about Levothyroxine EP impurity B including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C15H11ClI3NO4Purity:Min. 95%Molecular weight:685.42 g/mol5-Amino-4-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoic acid
CAS:5-Amino-4-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoic acid is a compound that contains a carbonyl group and a nitro group. It has been found to exhibit emission properties and has shown potential as an antiviral agent. This compound has also been studied for its effects on 27-hydroxycholesterol, a cholesterol metabolite involved in lipid peroxidation and inflammation. Additionally, it has been investigated for its interaction with tenofovir, an antiviral medication used to treat HIV/AIDS. The presence of hydroxyl groups in this compound suggests its potential as a precursor for the synthesis of oxysterols, which are important signaling molecules in the body. Impurities in this compound may be removed through purification processes to ensure its quality and effectiveness. Overall, this compound shows promise for further research in the field of antiviral drugs and lipid metabolism.
Formula:C13H13N3O6Purity:Min. 95%Molecular weight:307.26 g/molD-Sydnocarb
CAS:Please enquire for more information about D-Sydnocarb including the price, delivery time and more detailed product information at the technical inquiry form on this page
Formula:C18H18N4O2Purity:Min. 95%Molecular weight:322.4 g/molTrans-haloperidol N-oxide
CAS:Trans-haloperidol N-oxide is a pyridinium salt that has been used in the synthesis of other compounds. It is an intermediate in the formation of the anion, which arises due to hydrolysis of haloperidol. The anion can be converted to an n-oxide by treatment with hydrogen peroxide and acetic acid. Trans-haloperidol N-oxide can also be prepared by chromatography or kinetic studies. The analytical techniques employed include high performance liquid chromatography (HPLC) and gas chromatography/mass spectrometry (GC/MS).
Formula:C21H23ClFNO3Purity:Min. 95%Molecular weight:391.9 g/mol5-Ethyl-5-phenyl-2-(1-phenylpropyl)dihydropyrimidine-4,6(1H,5H)-dione
CAS:5-Ethyl-5-phenyl-2-(1-phenylpropyl)dihydropyrimidine-4,6(1H,5H)-dione is an impurity in the drug product of the drug 5-[3-(3,4-dihydroisoquinolin-2(1H)-yl)propoxy]-2,2'-bis[N-(2-hydroxyethyl)]ethaneamine. It is an analytical standard for HPLC and can be used as a pharmacopoeia or custom synthesis. It is also a metabolite of the drug 5-[3-(3,4-dihydroisoquinolin-2(1H)-yl)propoxy]-2,2'-bis[N-(2-hydroxyethyl)]ethaneamine.Formula:C21H24N2O2Purity:Min. 95%Color and Shape:White PowderMolecular weight:336.43 g/mol
